Trial intelligence / Profile preview

Effect of THC on Ocular Hemodynamics in Healthy Subjects

NCT03907163Phase 1Completed

Sponsor
Medical University of Vienna
Start
Jul 2018
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of dronabinol in Glaucoma (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Optic nerve head blood flow at 60 minutes. Started Jul 2018; status: completed.

02

Drugs

dronabinol
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT03907163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03907163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call